Enumera Molecular

About:

Enumera Molecular is developing a scalable biomolecule assessment platform enabling lower-cost, rapid clinical liquid biopsy tests.

Website: https://www.enumeramolecular.com/

Top Investors: Arboretum Ventures

Description:

Enumera Molecular is a life science tools company headquartered in Ann Arbor, MI, developing a scalable biomolecule assessment platform enabling lower-cost, rapid clinical liquid biopsy tests. It helps in transforming the field of clinical molecular testing into a simpler, more actionable tool for physicians to benefit patient care.

Total Funding Amount:

$12.5M

Headquarters Location:

Ann Arbor, Michigan, United States

Founded Date:

2022-01-01

Founders:

Matthew Cooper

Number of Employees:

11-50

Last Funding Date:

2022-05-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai